US FDA bolsters tendon damage warnings for fluoroquinolones
This article was originally published in Scrip
Executive Summary
The US FDAis requiring that sponsors of systemic fluoroquinolone antibiotics add a "black box" label warning about the risk of tendinitis and tendon rupture.